All News

HB 952, a bill that would have allow for tribal nations and the governor’s office to be able to form compacts to legalize cannabis and regulate it on individual reservations.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD explains the cannabis projects and companies she is actively involved in, her goals for the future, plus past guests on her podcast, The Dank Hour.

Here, we bring you our top five recent articles covering medical cannabis in Texas, cease-and-desist letter response, pardons in Maryland, cannabis in Thailand, and research on autism and cannabis.

Intoxicating hemp-derived THC products are now banned in Arkansas and creates a little bit of controversy regarding the recent bill veto by Texas Governor Abbott.

The newly published regulations classify cannabis flowers as controlled herbs, requiring prescriptions and licensed handling.

Wyld has joined The Conservation Alliance as a Pinnacle Member and becomes the first cannabis brand to reach this level.

The acquisition is anticipated to provide a foothold in two states and allow for further expansion in additional locations.

ONE HEMP announced their support of the SB 3 veto from Texas Governor Greg Abbott.

Results included improvements in aggression, hyperactivity, and communication, but a strong placebo effect was also observed.

Industry organizations respond after Governor Greg Abbott vetoed SB 3, citing safety and legal concerns.

Strong Strains recently responded to the cease-and-desist letter from the property owners regarding their new Long Island dispensary in East Setauket, New York.

Maryland Governor Wes Moore announced that he would be pardoning 7,000 people who had been convicted of crimes related to cannabis.

Here, we bring you our top five recent articles covering medical cannabis in Hawaii, a new dispensary in Connecticut, pesticide testing in California, a cease-and-desist letter to a dispensary on Long Island, and a global survey on cannabis for endometriosis.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD shares insights into genetic characteristics of the cannabis plant and potential research into disease resistance.

The study tested the effects of real-world cannabis products categorized by four modes of administration: dabbing, vaping, bong-like, or joint-like products.

A legal cannabis dispensary on Long Island, located within the Brookhaven Town, received a cease-and-desist letter before their upcoming grand opening.

Proposed regulations from the Department of Health would make permanent the emergency rules banning THC in hemp-derived food, beverage, and dietary products while restricting sales to adults 21 and older.

C3 Industries announced the recent opening of their new High Profile Stratford Connecticut dispensary.

A survey of nearly 900 endometriosis patients across 28 countries highlights cannabis as a preferred alternative to pharmaceuticals, despite legal, social, and medical communication barriers.

New Jersey Department of State’s NJBAC completed the CTA program which helps educate businesses on the states’ cannabis industry.

Proposed changes include revised action levels for 31 pesticides and the addition of 14 pesticides for required testing.

A recent study found that CBD gummies may not have accurate labeling on how much the cannabinoid it contains.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD exlains the cost, services, and benefits of cannabis genotyping.

Here, we bring you our top five recent articles covering safety regulations in North Carolina, licenses in Minnesota, the FDA’s FY2026 Agriculture appropriations bill, cannabis taxes in California, and antifungal properties of CBD and CBDV.

Hawaii Governor Josh Green vetoes bill that would have allowed medical cannabis patients to be certified via telehealth.

Researchers analyzed national data over a 16-year timeframe to identify who receives treatment for cannabis use disorder (CUD).

The USDA recently sent out a letter to all SNAP retailers issuing clarification on SNAP benefits, listing cannabis products as ineligible items.

Several cease and desist letters were sent to companies in regard to hemp products containing THCA that potentially violate the Missouri Merchandising Practices Act.